Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'HEMOPHILIA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 2156 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Smales, CM; Pepper, DS; James, DC
      Protein modifications during antiviral heat bioprocessing and subsequent storage

      BIOTECHNOLOGY PROGRESS
    2. Liu, P; Kalajzic, I; Stover, ML; Rowe, DW; Lichtler, AC
      Human bone marrow stromal cells are efficiently transduced by vesicular stomatitis virus-pseudotyped retrovectors without affecting subsequent osteoblastic differentiation

      BONE
    3. Rogers, AS; Lindsey, JC; Donfield, S; D'Angelo, LJ
      HIV-1 RNA levels and development of clinical disease in two different adolescent populations

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    4. Favre, D; Provost, N; Blouin, V; Blacho, G; Cherel, Y; Salvetti, A; Moullier, P
      Immediate and long-term safety of recombinant adeno-associated virus injection into the nonhuman primate muscle

      MOLECULAR THERAPY
    5. Arruda, VR; Fields, PA; Milner, R; Wainwright, L; De Miguel, MP; Donovan, PJ; Herzog, RW; Nichols, TC; Biegel, JA; Razavi, M; Dake, M; Huff, D; Flake, AW; Couto, L; Kay, MA; High, KA
      Lack of germline transmission of vector sequences following systemic administration of recombinant AAV-2 vector in males

      MOLECULAR THERAPY
    6. Park, F; Kay, MA
      Modified HIV-1 based lentiviral vectors have an effect on viral transduction efficiency and gene expression in vitro and in vivo

      MOLECULAR THERAPY
    7. Nicklin, SA; Buening, H; Dishart, KL; de Alwis, M; Girod, A; Hacker, U; Thrasher, AJ; Ali, RR; Hallek, M; Baker, AH
      Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells

      MOLECULAR THERAPY
    8. Herzog, RW; Mount, JD; Arruda, VR; High, KA; Lothrop, CD
      Muscle-directed gene transfer and transient immune suppression result in sustained partial correction of canine hemophilia B caused by a null mutation

      MOLECULAR THERAPY
    9. Fields, PA; Arruda, VR; Armstrong, E; Chu, K; Mingozzi, F; Hagstrom, JN; Herzog, RW; High, KA
      Risk and prevention of anti-factor IX formation in AAV-mediated gene transfer in the context of a large deletion of F9

      MOLECULAR THERAPY
    10. Chao, HJ; Monahan, PE; Liu, YB; Samulski, RJ; Walsh, CE
      Sustained and complete phenotype correction of hemophilia B mice followingintramuscular injection of AAV1 serotype vectors

      MOLECULAR THERAPY
    11. Stein, CS; Kang, Y; Sauter, SL; Townsend, K; Staber, P; Derksen, TA; Martins, I; Qian, J; Davidson, BL; McCray, PB
      In vivo treatment of hemophilia A and mucopolysaccharidosis type VII usingnonprimate lentiviral vectors

      MOLECULAR THERAPY
    12. Miao, CH; Thompson, AR; Loeb, K; Ye, X
      Long-term and therapeutic-level hepatic gene expression of human factor IXafter naked plasmid transfer in vivo

      MOLECULAR THERAPY
    13. Sanftner, LHM; Rendahl, KG; Quiroz, D; Coyne, M; Ladner, M; Manning, WC; Flannery, JG
      Recombinant AAV-mediated delivery of a tet-inducible reporter gene to the rat retina

      MOLECULAR THERAPY
    14. McCormack, JE; Edwards, W; Sensintaffer, J; Lillegren, L; Kozloski, M; Brumm, D; Karavodin, L; Jolly, DJ; Greengard, J
      Factors affecting long-term expression of a secreted transgene product after intravenous administration of a retroviral vector

      MOLECULAR THERAPY
    15. Fewell, JG; MacLaughlin, F; Mehta, V; Gondo, M; Nicol, F; Wilson, E; Smith, LC
      Gene therapy for the treatment of hemophilia B using PINC-formulated plasmid delivered to muscle with electroporation

      MOLECULAR THERAPY
    16. Chen, ZY; Yant, SR; He, CY; Meuse, L; Shen, S; Kay, MA
      Linear DNAs concatemerize in vivo and result in sustained transgene expression in mouse liver

      MOLECULAR THERAPY
    17. Mazurier, C; Goudemand, J; Hilbert, L; Caron, C; Fressinaud, E; Meyer, D
      Type 2N von Willebrand disease: clinical manifestations, pathophysiology, laboratory diagnosis and molecular biology

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    18. Kouides, PA
      Obstetric and gynaecological aspects of von Willebrand disease

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    19. Mannucci, PM; Federici, AB
      Management of inherited von Willebrand disease

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    20. Salkowitz, JR; Purvis, SF; Meyerson, H; Zimmerman, P; O'Brien, TR; Aledort, L; Eyster, ME; Hilgartner, M; Kessler, C; Konkle, BA; White, GC; Goedert, JJ; Lederman, MM
      Characterization of high-risk HIV-1 seronegative hemophiliacs

      CLINICAL IMMUNOLOGY
    21. Minhas, HL; Giangrande, PLF
      Presentation of severe haemophilia - A role for accident and emergency doctors?

      EMERGENCY MEDICINE JOURNAL
    22. Chiou, HC; Lucas, MA; Coffin, CC; Banaszczyk, MG; Ill, CR; Lollo, CP
      Gene therapy strategies for the treatment of chronic viral hepatitis

      EXPERT OPINION ON BIOLOGICAL THERAPY
    23. Emanuel, BS; Shaikh, TH
      Segmental duplications: An 'expanding' role in genomic instability and disease

      NATURE REVIEWS GENETICS
    24. Pflegerl, K; Hahn, R; Schallaun, E; Josic, D; Jungbauer, A
      Quantification of plasma-derived blood coagulation factor VIII by real-time biosensor measurements

      JOURNAL OF CHROMATOGRAPHY B
    25. Liras, A
      Gene therapy for haemophilia: the end of a 'royal pathology' in the third millennium?

      HAEMOPHILIA
    26. Fischer, K; Van der Bom, JG; Mauser-Bunschoten, EP; Roosendaal, G; Prejs, R; Grobbee, DE; Van den Berg, HM
      Changes in treatment strategies for severe haemophilia over the last 3 decades: effects on clotting factor consumption and arthropathy

      HAEMOPHILIA
    27. Wallny, T; Hess, L; Seuser, A; Zander, D; Brackmann, HH; Kraft, CN
      Pain status of patients with severe haemophilic arthropathy

      HAEMOPHILIA
    28. Miners, AH; Sabin, CA; Tolley, KH; Parnaby, A; Lee, CA
      Assessing the relationship between productivity levels and severity of haemophilia

      HAEMOPHILIA
    29. Timur, AA; Gurgey, A; Aktuglu, G; Kavakli, K; Canatan, D; Olek, K; Caglayan, SH
      Molecular pathology of haemophilia A in Turkish patients: identification of 36 independent mutations

      HAEMOPHILIA
    30. Gilchrist, GS; Wilke, JL; Muehlenbein, LR; Danilenko-Dixon, D
      Intrauterine correction of factor VIII (FVIII) deficiency

      HAEMOPHILIA
    31. Mukhopadhyay, S; Saxena, R; Kashyap, R; Choudhry, VP
      Danazol therapy in factor X deficiency

      HAEMOPHILIA
    32. Hothi, DK; Kelsall, W; Baglin, T; Williams, DM
      Bacterial endocarditis in a child with haemophilia B: risks of central venous catheters

      HAEMOPHILIA
    33. Vianello, F; Belvini, D; Dal Bello, F; Tagariello, G; Zanon, E; Lombardi, AM; Zerbinati, P; Girolami, A
      Mild bleeding diathesis in a boy with combined severe haemophilia B (C-10400 -> T) and heterozygous factor V Leiden

      HAEMOPHILIA
    34. Cooper, HA; Jones, CP; Campion, E; Roberts, HR; Hedner, U
      Rationale for the use of high dose rFVIIa in a high-titre inhibitor patient with haemophilia B during major orthopaedic procedures

      HAEMOPHILIA
    35. Meiklejohn, DJ; Watson, HG
      Acquired haemophilia in association with organ-specific autoimmune disease

      HAEMOPHILIA
    36. Shittu, OB; Shokunbi, WA
      Circumcision in haemophiliacs: the Nigerian experience

      HAEMOPHILIA
    37. Scharrer, I; Ehrlich, HJ
      Lack of evidence for increased inhibitor incidence in patients switched from plasma-derived to recombinant factor VIII

      HAEMOPHILIA
    38. Rizza, CR; Hill, FGH; Spooner, RJD; Giangrande, PLF
      Treatment of haemophilia in the United Kingdom 1981-1996

      HAEMOPHILIA
    39. Mauser-Bunschoten, EP; van der Bom, JG; Bongers, M; Twijnstra, M; Roosendaal, G; Fischer, K; van den Berg, HM
      Purity of factor VIII product and incidence of inhibitors in previously untreated patients with haemophilia A

      HAEMOPHILIA
    40. Theophilus, BDM; Enayat, MS; Williams, MD; Hill, FGH
      Site and type of mutations in the factor VIII gene in patients and carriers of haemophilia A

      HAEMOPHILIA
    41. Acquila, M; Bottini, F; Valetto, A; Caprino, D; Mori, PG; Bicocchi, MP
      A new strategy for prenatal diagnosis in a sporadic haemophilia B family

      HAEMOPHILIA
    42. Bauduer, F; Ducout, L; Bendriss, P; Falaises, B; Lavergne, JM
      Mild haemophilia A discovered in a previously multi-operated 73-year-old man: characterization of a new mutation

      HAEMOPHILIA
    43. Mazzucconi, MG; Bizzoni, L; Giorgi, A; Morano, SG; Peraino, M; Russo, M; Alimena, G
      Postpartum inhibitor to factor VIII: treatment with high-dose immunoglobulin and dexamethasone

      HAEMOPHILIA
    44. Godreuil, S; Navarro, R; Quittet, P; Landreau, L; Schved, JF; Biron-Andreani, C
      Acquired haemophilia in the elderly is a severe disease: report of five new cases

      HAEMOPHILIA
    45. Yoshioka, A; Shima, M; Fukutake, K; Takamatsu, J; Shirahata, A
      Safety and efficacy of a new recombinant FVIII formulated with sucrose (rFVIII-FS) in patients with haemophilia A: a long-term, multicentre clinical study in Japan

      HAEMOPHILIA
    46. Josic, D; Kannicht, C; Loster, K; Pock, K; Iberer, G; Buchacher, A
      Vitronectin in clotting factor IX concentrates

      HAEMOPHILIA
    47. Leissinger, C; Becton, D; Cornell, C; Gill, JC
      High-dose DDAVP intranasal spray (Stimate((R))) for the prevention and treatment of bleeding in patients with mild haemophilia A, mild or moderate type 1 von Willebrand disease and symptomatic carriers of haemophilia A

      HAEMOPHILIA
    48. Astermark, J; Berntorp, E; White, GC; Kroner, BL
      The Malmo International Brother Study (MIBS): further support for genetic predisposition to inhibitor development

      HAEMOPHILIA
    49. Ghosh, K; Shetty, S; Kulkarni, B; Nair, S; Pawar, A; Khare, A; Baindur, S; Mohanty, D
      Development of inhibitors in patients with haemophilia from India

      HAEMOPHILIA
    50. Ekert, H; Brewin, T; Boey, W; Davey, P; Tilden, D
      Cost-utility analysis of recombinant factor VIIa (NovoSeven((R))) in six children with long-standing inhibitors to factor VIII or IX

      HAEMOPHILIA
    51. Schoenmakers, MAGC; Gulmans, VAM; Helders, PJM; Van den Berg, HM
      Motor performance and disability in Dutch children with haemophilia: a comparison with their healthy peers

      HAEMOPHILIA
    52. Soares, RPS; Chamone, DAF; Bydlowski, SP
      Factor VIII gene inversions and polymorphisms in Brazilian patients with haemophilia A: carrier detection and prenatal diagnosis

      HAEMOPHILIA
    53. Klein, I; Andrikovics, H; Bors, A; Nemes, L; Tordai, A; Varadi, A
      A haemophilia A and B molecular genetic diagnostic programme in Hungary: ahighly informative and cost-effective strategy

      HAEMOPHILIA
    54. Faradji, A; Bonnomet, F; Lecocq, J; Grunebaum, L; Desprez, D; Kern, O; Barbier, L; Sibilia, J
      Knee joint arthroplasty in a patient with haemophilia A and high inhibitortitre using recombinant factor VIIa (NovoSeven((R))): a new case report and review of the literature

      HAEMOPHILIA
    55. Kashyap, R; Choudhry, VP; Mahapatra, M; Chumber, S; Saxena, R; Kaul, HL
      Postpartum acquired haemophilia: clinical recognition and management

      HAEMOPHILIA
    56. Samaiya, A; Gupta, S; Chumber, S; Kashyap, R; Dewanda, NK; Vashisht, S; Choudhry, VP
      Blunt abdominal trauma with delayed rupture of splenic haematoma in a haemophiliac patient

      HAEMOPHILIA
    57. Yenchitsomanus, P; Thanootarakul, P; Akkarapatumwong, V; Oranwiroon, S; Pung-Amritt, P; Veerakul, G; Mahasandana, C
      Mutation causing exon 15 skipping and partial exon 16 deletion in factor VIII transcript, and a method for direct mutation detection

      HAEMOPHILIA
    58. Bjorkman, S; Shapiro, AD; Berntorp, E
      Pharmacokinetics of recombinant factor IX in relation to age of the patient: implications for dosing in prophylaxis

      HAEMOPHILIA
    59. Chowdary, P; Dasani, H; Jones, JAH; Loran, CM; Eldridge, A; Hughes, S; Collins, PW
      Recombinant factor IX (BeneFix (R)) by adjusted continuous infusion: a study of stability, sterility and clinical experience

      HAEMOPHILIA
    60. Philipp, CS
      Viral safety of a pasteurized, monoclonal antibody-purified factor VIII concentrate in previously untreated haemophilia A patients

      HAEMOPHILIA
    61. Haya, S; Lopez, MF; Aznar, JA; Batlle, J
      Immune tolerance treatment in haemophilia patients with inhibitors: the Spanish Registry

      HAEMOPHILIA
    62. Dykes, AC; Walker, ID; Lowe, GDO; Tait, RC
      Combined prednisolone and intravenous immunoglobulin treatment for acquired factor VIII inhibitors: a 2-year review

      HAEMOPHILIA
    63. Grunewald, M; Beneke, H; Guthner, C; Germowitz, A; Brommer, A; Griesshammer, M
      Acquired haemophilia: experiences with a standardized approach

      HAEMOPHILIA
    64. Soucie, JM; Symons, J; Evatt, B; Brettler, D; Huszti, H; Linden, J
      Home-based factor infusion therapy and hospitalization for bleeding complications among males with haemophilia

      HAEMOPHILIA
    65. Hortelano, G; Wang, L; Xu, N; Ofosu, FA
      Sustained and therapeutic delivery of factor IX in nude haemophilia B miceby encapsulated C2C12 myoblasts: concurrent tumourigenesis

      HAEMOPHILIA
    66. Puetz, JJ; Bouhasin, JD
      High-titre factor VIII inhibitor in two children with mild haemophilia A

      HAEMOPHILIA
    67. Kouides, PA; Kulzer, L
      Prophylactic treatment of severe factor X deficiency with prothrombin complex concentrate

      HAEMOPHILIA
    68. Sheth, S; DiMichele, D; Lee, M; Lamour, J; Quaegebeur, J; Hsu, D; Addonizio, L; Piomelli, S
      Heart transplant in a factor VIII-deficient patient with a high-titre inhibitor: perioperative management using high-dose continuous infusion factor VIII and recombinant factor VIIa

      HAEMOPHILIA
    69. Rodriguez-Merchan, EC
      Methods to treat chronic haemophilic synovitis

      HAEMOPHILIA
    70. Aguilar, C; Lucia, JF; Simon, MA
      An emerging role for interferon in haemophiliacs with chronic hepatitis C?

      HAEMOPHILIA
    71. Ghosh, K; Shetty, S; Mohanty, D
      Milder clinical presentation of haemophilia A with severe deficiency of factor VIII as measured by one-stage assay

      HAEMOPHILIA
    72. Mondorf, W; Klinge, J; Luban, NLC; Bray, G; Saenko, E; Scandella, D
      Low factor VIII recovery in haemophilia A patients without inhibitor titreis not due to the presence of anti-factor VIII antibodies undetectable by the Bethesda assay

      HAEMOPHILIA
    73. Oranwiroon, S; Akkarapatumwong, V; Pung-Amritt, P; Treesucon, A; Veerakul, G; Mahasandana, C; Panyim, S; Yenchitsomanus, P
      Determination of haemophilia A carrier status by mutation analysis

      HAEMOPHILIA
    74. Klinge, J; Auerswald, G; Budde, U; Klose, H; Kreuz, W; Lenk, H; Scandella, D
      Detection of all anti-factor VIII antibodies in haemophilia A patients by the Bethesda assay and a more sensitive immunoprecipitation assay

      HAEMOPHILIA
    75. Rocino, A; Papa, ML; Salerno, E; Capasso, F; Miraglia, E; De Biasi, R
      Immune tolerance induction in haemophilia A patients with high-responding inhibitors to factor VIII: experience at a single institution

      HAEMOPHILIA
    76. Solovieva, S
      Clinical severity of disease, functional disability and health-related quality of life. Three-year follow-up study of 150 Finnish patients with coagulation disorders

      HAEMOPHILIA
    77. Schultz, JR; Butler, RB; McKernan, L; Boelsen, R
      Developing theory-based risk-reduction interventions for HIV-positive young people with haemophilia

      HAEMOPHILIA
    78. Calvez, T; Biou, M; Costagliola, D; Jullien, AM; Laurian, Y; Rossi, F; Rothschild, C; Sie, P
      The French haemophilia cohort: rationale and organization of a long-term national pharmacosurveillance system

      HAEMOPHILIA
    79. Miller, R
      The responsibility of separating truth from myth to patient and family

      HAEMOPHILIA
    80. Mauser-Bunschoten, EP; Roosendaal, G; Van den Berg, HM
      Product choice and haemophilia treatment in the Netherlands

      HAEMOPHILIA
    81. Petrini, P
      What factors should influence the dosage and interval of prophylactic treatment in patients with severe haemophilia A and B?

      HAEMOPHILIA
    82. Penner, JA
      Haemophilic patients with inhibitors to factor VIII or IX: variables affecting treatment response

      HAEMOPHILIA
    83. Berntorp, E
      Immune tolerance induction: recombinant vs. human-derived product

      HAEMOPHILIA
    84. Srivastava, A
      Choice of factor concentrates for haemophilia: a developing world perspective

      HAEMOPHILIA
    85. Gilbert, MS; Cornwall, R
      The history of synoviorthesis in haemophilia

      HAEMOPHILIA
    86. Querol, F; Rodriguez-Merchan, EC; Aznar, JA; Lopez-Cabarcos, C; Villar, A
      Post-synoviorthesis rehabilitation in haemophilia

      HAEMOPHILIA
    87. Aledort, LM
      Making a therapeutic choice: human versus recombinant fractions - can we do it?

      HAEMOPHILIA
    88. Hoots, WK
      The future of plasma-derived clotting factor concentrates

      HAEMOPHILIA
    89. Ewenstein, BM
      Use of ristocetin cofactor activity in the management of von Willebrand disease

      HAEMOPHILIA
    90. High, KA
      Gene therapy: a 2001 perspective

      HAEMOPHILIA
    91. Ragni, MV
      New-generation recombinant factor concentrates: bridge to gene therapy

      HAEMOPHILIA
    92. Ebid, AHIM; Shelton, MJ; Adams, JM; Cordaro, JA; Gugino, LJ; Maliszewski, M; Colomaio, R; Hewitt, RG; Morse, GD
      Menstrual cycle and zidovudine pharmacokinetics in HIV-infected women

      CLINICAL DRUG INVESTIGATION
    93. Castro, RR; Relinque, NB; Alvarez, AC; Montes, JMG; Gutierrez, JMH
      Use of recombinant factor VII in Hepatology

      REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
    94. Turgeman, G; Pittman, DD; Muller, R; Kurkalli, BG; Zhou, SH; Pelled, G; Peyser, A; Zilberman, Y; Moutsatsos, IK; Gazit, D
      Engineered human mesenchymal stem cells: a novel platform for skeletal cell mediated gene therapy

      JOURNAL OF GENE MEDICINE
    95. Chuah, MKL; Collen, D; VandenDriessche, T
      Gene therapy for hemophilia

      JOURNAL OF GENE MEDICINE
    96. Mitchell, W
      Neurological and developmental effects of HIV and AIDS in children and adolescents

      MENTAL RETARDATION AND DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS
    97. Peterson, SR; Joseph, AK
      Inherited bleeding disorders, in dermatologic surgery

      DERMATOLOGIC SURGERY
    98. Poon, MC
      Use of recombinant factor VIIa in hereditary bleeding disorders

      CURRENT OPINION IN HEMATOLOGY
    99. Li, XM; Scaringe, WA; Hill, KA; Roberts, S; Mengos, A; Careri, D; Pinto, MT; Kasper, CK; Sommer, SS
      Frequency of recent retrotransposition events in the human factor IX gene

      HUMAN MUTATION
    100. D'Angelo, LJ; Abdalian, SE; Sarr, M; Hoffman, N; Belzer, M
      Disclosure of serostatus by HIV infected youth: The experience of the REACH study

      JOURNAL OF ADOLESCENT HEALTH


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/08/20 alle ore 04:24:24